The potential of Rapamycin as a selected drug for apoptosis induction in triple negative breast cancer subtype using high-throughput transcriptome analysis
Triple-negative breast cancers (TNBC), which lack estrogen and progesterone receptors demonstrate HER2/neu overexpression. The poor survival outcomes coupled with TNBC patients are partially, due to a lack ... patients…

